Biotech stocks down at noon
Wednesday, 11 March, 2009
At 12:30pm the pharmaceuticals index was down 1.3%, bucking the positive overall trend on the ASX which was up almost 2% after big rises on Wall Street overnight.
Index heavyweight CSL (ASX:CSL) accounted for the bulk of the slippage with a drop of 77c to $34.68.
Prana Biotechnology (ASX:PBT) moved up 1.5c, or over 9%, to 17.5c.
Novogen (ASX:NRT) also showed a 6% increase up 2.5c to 45c from yesterday’s lows.
Sigma Pharmaceuticals (ASX:SIP) was down 1% to 95c in light volume.
Cartherics and Catalent announce enhanced partnership
To support immune cell therapy products for the treatment of cancer and endometriosis, Australian...
Alliance seeks to boost regional capacity in clinical trials
Launched this week, the Barwon Health–Deakin University Clinical Trials Alliance is...
Lipid science receives new Australia-led online hub
The Lipid Network launched this month to build links between researchers, clinicians and industry...
